Search Drug Information, Interactions, Images, Dosage & Side Effects

ICS, OCS use in asthma may carry bone health risks 18 Dec 2020

Patients with asthma who are treated with inhaled or oral corticosteroids may have an elevated risk of osteoporosis or fragility fracture, according to a study from the UK.

Mepolizumab shows promise against hypereosinophilic syndrome

18 Dec 2020

Obesity portends worse outcomes in COVID-19, even for young adults

18 Dec 2020

Can gargling with mouthwash stop coronavirus from its tracks?

18 Dec 2020

Substantial prevalence of burnout seen in rheumatologists

18 Dec 2020

Intravesical BCG therapy safe to use in older patients with bladder cancer

18 Dec 2020

Fruit, vegetable intake prevents frailty in older women

18 Dec 2020

Omecamtiv mecarbil: New player in HF treatment?

18 Dec 2020

Sponsored posts on e-cigarettes perform worse on social media

18 Dec 2020

Folate, vitamin B12 implicated in gestational diabetes

18 Dec 2020

High fish, omega-3 consumption may ward off postpartum depression

18 Dec 2020

Expanding role of SGLT2 inhibitors in T2DM and HF management 09 Dec 2020;
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have demonstrated benefits in cardiovascular (CV) outcome trials in patients with type 2 diabetes mellitus (T2DM). A post hoc analysis of the EMPA-REG OUTCOME trial showed early reductions in CV mortality and hospitalization for heart failure (HHF) with empagliflozin, while new data from the real-world EMPRISE study continue to support empagliflozin’s cardioprotective effect in patients with a broader CV risk profile. In the EMPEROR-Reduced trial, empagliflozin treatment yielded cardiorenal benefits in patients with heart failure with reduced ejection fraction (HFrEF), regardless of T2DM status. The clinical impact of these recent findings was discussed by Professor Guntram Schernthaner of the Rudolfstiftung Hospital and Medical University of Vienna, Vienna, Austria, at the Endocrinology, Diabetes & Metabolism Hong Kong 3rd Annual Meeting (EDMHK 2020).

Latest advances in diagnosis and management of axial spondyloarthritis

Dr. Ho-Yin Chung, Prof. Mitsumasa Kishimoto, Prof. James Wei, 09 Dec 2020

A fixed-dose combination of a selective beta-blocker and a calcium channel blocker for hypertension

Prof. Sverre E. Kjeldsen, Dr. Andy Wai-Kwong Chan, 09 Dec 2020

Use of a β-lactam antibiotic/β-lactamase inhibitor combination in a patient with multidrug-resistant pneumonia and multiple comorbidities

Dr. Andrew Tin-Yau Wong, 09 Dec 2020

Vyzulta

Contents : Latanoprostene bunod

Indications/Uses : Reduction of IOP in patients w/ open-angle glaucoma or ocular HTN.

Dupixent

Contents : Dupilumab

Indications/Uses : Moderate to severe atopic dermatitis in adults & adolescents ≥12 yr who are candidates for systemic therapy. Add-on maintenance treatment for severe asthma w/ type 2 inflammation characterised by raised blood eosinophils &/or raised FeNO in adults & adolescents ≥12 yr who are inadequately controlled w/ high dose inhaled corticosteroid (ICS) plus another medicinal product for maintenance treatment.